![Tina Gullotta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tina Gullotta
Comptroller/Controller/Auditor chez
SPRUCE BIOSCIENCES, INC.
Profil
Tina Gullotta is Vice President-Finance & Controller at Spruce Biosciences, Inc. since 2026.
Former roles include CFO, Chief Accounting Officer & Vice President at Sunesis Pharmaceuticals, Inc. in 2021; Head-Investor Relations & Controller at Atara Biotherapeutics, Inc. from 2014 to 2018; and Vice President-Finance at Frontier Medicines Corp.
Education includes undergraduate studies at Santa Clara University.
Postes actifs de Tina Gullotta
| Sociétés | Poste | Début |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 15/06/2026 |
Anciens postes connus de Tina Gullotta
| Sociétés | Poste | Fin |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Directeur Financier/CFO | 24/02/2021 |
| ATARA BIOTHERAPEUTICS, INC. | Investor Relations Contact | 01/01/2018 |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Corporate Officer/Principal | - |
Formation de Tina Gullotta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Health Technology |
Choisissez Zonebourse 
